Cargando…

Repurposing Niclosamide as a Therapeutic Drug against Acute Liver Failure by Suppressing Ferroptosis

Acute liver failure (ALF) is a severe liver disease with a high mortality rate without effective therapeutic drugs. Ferroptosis is a form of programmed cell death that plays an important role in ALF. In this study, we aimed to identify ferroptosis-related genes in ALF, thereby predicting promising c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Xiao, Fan, Xue-Gong, Chen, Ruochan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383467/ https://www.ncbi.nlm.nih.gov/pubmed/37514136 http://dx.doi.org/10.3390/pharmaceutics15071950

Ejemplares similares

Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
por: Tharmalingam, Nagendran, et al.
Publicado: (2018)

Niclosamide as a Repurposing Drug against Corynebacterium striatum Multidrug-Resistant Infections
por: Folliero, Veronica, et al.
Publicado: (2022)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
por: Hamdoun, Sami, et al.
Publicado: (2017)

Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
por: Tanaka, Takeshi, et al.
Publicado: (2022)

Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy
por: Kim, Hyun-Jun, et al.
Publicado: (2021)

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
por: Miner, Kent, et al.
Publicado: (2019)

Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018)

An Integrated Bioinformatics Analysis Repurposes an Antihelminthic Drug Niclosamide for Treating HMGA2-Overexpressing Human Colorectal Cancer
por: Leung, Stephen Wan, et al.
Publicado: (2019)

Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147
por: Yang, Zhe, et al.
Publicado: (2023)

Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147
por: Yang, Zhe, et al.
Publicado: (2023)

Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide
por: Bhattacharya, Udayan, et al.
Publicado: (2023)

Niclosamide Is Active In Vitro against Mycetoma Pathogens
por: Mahmoud, Abdelhalim B., et al.
Publicado: (2021)

NICLOSAMIDE-EXFOLIATED ANIONIC CLAY NANOHYBRID REPURPOSED AS AN ANTIVIRAL DRUG FOR TACKLING COVID-19; ORAL FORMULATION WITH TWEEN 60/EUDRAGIT S100
por: Rejinold, N. Sanoj, et al.
Publicado: (2021)

Niclosamide suppresses T-cell acute lymphoblastic leukemia growth through activation of apoptosis and autophagy
por: Huang, Fang-Liang, et al.
Publicado: (2022)

Niclosamide suppresses Hepatoma cell proliferation via the Wnt pathway
por: Tomizawa, Minoru, et al.
Publicado: (2013)

Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress
por: Wang, Yao, et al.
Publicado: (2019)

GAS1 Promotes Ferroptosis of Liver Cells in Acetaminophen-Induced Acute Liver Failure
por: Tao, Jinqiu, et al.
Publicado: (2023)

Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β
por: Kaushal, Jyoti B., et al.
Publicado: (2021)

The magic bullet: Niclosamide
por: Jiang, Haowen, et al.
Publicado: (2022)

Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
por: Wang, Yu-Ming, et al.
Publicado: (2016)

Niclosamide suppresses renal cell carcinoma by inhibiting Wnt/β-catenin and inducing mitochondrial dysfunctions
por: Zhao, Juan, et al.
Publicado: (2016)

Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing)
por: Fan, XiuZhen, et al.
Publicado: (2019)

Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
por: Oh, Hyeong-Cheol, et al.
Publicado: (2020)

Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19
por: Pindiprolu, Sai Kiran S.S., et al.
Publicado: (2020)

Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways
por: Chae, Hee-Don, et al.
Publicado: (2017)

Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure
por: Tafere, Gebrehiwot Gebremedhin, et al.
Publicado: (2020)

Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases
por: Wang, Zhan, et al.
Publicado: (2022)

Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer
por: Kang, Borui, et al.
Publicado: (2023)

(+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis
por: Wang, Min, et al.
Publicado: (2020)

Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
por: Kang, Hee Eun, et al.
Publicado: (2021)

HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression
por: Liu, Guo-Zhen, et al.
Publicado: (2021)

New life for an old drug: In vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain
por: Zhang, Ji Li, et al.
Publicado: (2018)

Getting hands on a drug for Covid-19: Inhaled and Intranasal Niclosamide
por: Kunzelmann, Karl
Publicado: (2021)

Identification of a Novel Ferroptosis Inducer for Gastric Cancer Treatment Using Drug Repurposing Strategy
por: Zhang, Jinping, et al.
Publicado: (2022)

Overcoming cancer therapeutic bottleneck by drug repurposing
por: Zhang, Zhe, et al.
Publicado: (2020)

Repurposing of Benzimidazole Anthelmintic Drugs as Cancer Therapeutics
por: Song, Bomi, et al.
Publicado: (2022)

Binding interactions of niclosamide with serum proteins
por: Maltas, Esra
Publicado: (2014)

Niclosamide for Covid-19: bridging the gap
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Antitumor effect and metabonomics of niclosamide micelles
por: Hang, Jiarong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pa8a70eujj5prcmlkhflt1arhd